NeuroVasc Technologies
PrivateLast Round
Strategic
Feb 27, 2020
Total Funding Raised
$40.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NeuroVasc Technologies operates in Healthcare & Life Sciences and is based in Irvine, California. Its latest recorded funding round was a Strategic round in February 2020.
NeuroVasc Technologies is a medical device company that develops a portfolio of novel catheter-based technologies to facilitate broad treatment options for patients suffering from stroke and other neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroVasc Technologies Comparables
Compare NeuroVasc Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vesalio | 92% | |
| Anaconda Biomed S.L. | 87% | |
| RapidPulse | 87% |
For institutional investors. Book with your work email.
NeuroVasc Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Feb 27, 2020 | ||||
| Series B | May 16, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NeuroVasc Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ShangBay Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 50% MoM.
- Jan 20, 2026
Monthly visitors increased 58% MoM.
For institutional investors. Book with your work email.
NeuroVasc Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuroVasc Technologies's valuation, stock price, and market status.
Is NeuroVasc Technologies a public or private company?
NeuroVasc Technologies is a private company.
What is the current stock price of NeuroVasc Technologies?
NeuroVasc Technologies is a private company, so its shares have no public market price. Caplight tracks NeuroVasc Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuroVasc Technologies worth (valuation)?
Valuation information for NeuroVasc Technologies is not publicly available.
Can I buy NeuroVasc Technologies stock?
NeuroVasc Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuroVasc Technologies's last funding round?
NeuroVasc Technologies's most recent funding round was Strategic on February 27, 2020.
Who are the main investors in NeuroVasc Technologies?
Key investors in NeuroVasc Technologies include ShangBay Capital.
Will NeuroVasc Technologies IPO soon?
No public IPO plans have been announced for NeuroVasc Technologies.
How can I track NeuroVasc Technologies secondary market activity?
Caplight tracks bids, offers, and trades in NeuroVasc Technologies's shares on secondary markets.